Clinical Trial Update: Shingrix In Recipients of Allogeneic Transplants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Shingrix in recipients of allogeneic bone marrow or stem cell transplants is currently recruiting. The study aims to assess va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Bone Marrow Transplant, Stem Cell Transplant | Phase 2 | Status: RECRUITING